NEW YORK (GenomeWeb) – LexaGene announced today that it has partnered with Texas A&M Veterinary Medical Diagnostics Laboratory to test canine urine samples on LexaGene's LX6 prototype pathogen detection instrument.

Veterinarians at Texas A&M will send LexaGene clinically annotated urine samples for processing and pathogen detection on the firm's LX6 device. Before sending the samples to LexaGene, Texas A&M will characterize them using current diagnostic technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.